QuickView for organotechnetium compounds (compound)

1. Drug target sets for approved compounds

1. Recommendations for good clinical practice for DPD bone scintigraphy for cardiac amyloidosis.
2. Time is a gift: time-dependent uptake of DPD in cardiac amyloidosis.
3. Acute ischaemic hepatitis with secondary coagulopathy as an incidental finding on 99m Tc-3,3-diphosp…
4. Reduction in 99mTc-DPD myocardial uptake with therapy of ATTR cardiomyopathy.
5. 99mTc-FAPI uptake in a rare case of metastatic urachal carcinoma.

There were no clinical trials for organotechnetium compounds